Pharmaceutical Research, ISSN 0724-8741, 1/2016, Volume 33, Issue 1, pp. 18 - 39
Nanotechnology, in health and medicine, extensively improves the safety and efficacy of different therapeutic agents, particularly the aspects related to drug...
Biochemistry, general | Biomedical Engineering | Biomedicine | polymeric micelles | Pharmacy | hydrophobic core | nanotechnology | Medical Law | hydrophilic corona | cancer | Pharmacology/Toxicology | SYSTEM | CREMOPHOR-FREE | DOXORUBICIN | GENEXOL-PM | BIODISTRIBUTION | ANTITUMOR-ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | PACLITAXEL | PHASE-II TRIAL | ACID) BLOCK-COPOLYMER | PHARMACOLOGY & PHARMACY | O-SULFATE CHITOSAN | Animals | Humans | Micelles | Antineoplastic Agents - administration & dosage | Polymers | Nanotechnology | Drug Delivery Systems | Antimitotic agents | Drugs | Drug delivery systems | Drugstores | Chemical properties | Antineoplastic agents | Vehicles | Cancer
Biochemistry, general | Biomedical Engineering | Biomedicine | polymeric micelles | Pharmacy | hydrophobic core | nanotechnology | Medical Law | hydrophilic corona | cancer | Pharmacology/Toxicology | SYSTEM | CREMOPHOR-FREE | DOXORUBICIN | GENEXOL-PM | BIODISTRIBUTION | ANTITUMOR-ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | PACLITAXEL | PHASE-II TRIAL | ACID) BLOCK-COPOLYMER | PHARMACOLOGY & PHARMACY | O-SULFATE CHITOSAN | Animals | Humans | Micelles | Antineoplastic Agents - administration & dosage | Polymers | Nanotechnology | Drug Delivery Systems | Antimitotic agents | Drugs | Drug delivery systems | Drugstores | Chemical properties | Antineoplastic agents | Vehicles | Cancer
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 12/2018, Volume 35, Issue 12, pp. 1 - 1
The typesetter did not use the Fig. 6 provided by the author with his proof corrections, and instead duplicated Fig. 7 by the Fig. 6 caption. The original...
Biochemistry, general | Medical Law | Biomedicine | Pharmacology/Toxicology | Biomedical Engineering and Bioengineering | Pharmacy | Antimitotic agents | Antineoplastic agents | Tumors | Nanoparticles | Cheese | Polylactide-co-glycolide
Biochemistry, general | Medical Law | Biomedicine | Pharmacology/Toxicology | Biomedical Engineering and Bioengineering | Pharmacy | Antimitotic agents | Antineoplastic agents | Tumors | Nanoparticles | Cheese | Polylactide-co-glycolide
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 10/2019, Volume 36, Issue 10, pp. 1 - 17
Combinatorial approach can be beneficial for cancer treatment with better patient recovery. Co-delivery of natural and synthetic anticancer drug not only...
Biochemistry, general | encapsulation | in vivo pharmacokinetics | Biomedicine | PLGA-doxorubicin conjugate | necrosis | Pharmacy | mitochondrial pathway | Medical Law | Pharmacology/Toxicology | Biomedical Engineering and Bioengineering | berberine | CELLS | DESIGN | DOXORUBICIN | NANOMEDICINE | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | BREAST-CANCER | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | EFFICIENT | Nanoparticles | Anthracyclines | Usage | Permeability | Cell death | Encapsulation | Biotechnology | Drug delivery systems | Toxicity | Carbodiimide | Membrane permeability | Confocal microscopy | Doxorubicin | Necrosis | Polylactide-co-glycolide | Anticancer properties | Depolarization | Mitochondria | Glycolic acid | Cell cycle | Reaction kinetics | Biocompatibility | Membrane potential | G1 phase | Berberine | Exploration | Breast cancer | Tumor cell lines | Organic chemistry | Microscopy | Cell lines | Antitumor activity | In vivo methods and tests | Kinetics | Conjugation | Annexin V | Combinatorial analysis | Cancer
Biochemistry, general | encapsulation | in vivo pharmacokinetics | Biomedicine | PLGA-doxorubicin conjugate | necrosis | Pharmacy | mitochondrial pathway | Medical Law | Pharmacology/Toxicology | Biomedical Engineering and Bioengineering | berberine | CELLS | DESIGN | DOXORUBICIN | NANOMEDICINE | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | BREAST-CANCER | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | EFFICIENT | Nanoparticles | Anthracyclines | Usage | Permeability | Cell death | Encapsulation | Biotechnology | Drug delivery systems | Toxicity | Carbodiimide | Membrane permeability | Confocal microscopy | Doxorubicin | Necrosis | Polylactide-co-glycolide | Anticancer properties | Depolarization | Mitochondria | Glycolic acid | Cell cycle | Reaction kinetics | Biocompatibility | Membrane potential | G1 phase | Berberine | Exploration | Breast cancer | Tumor cell lines | Organic chemistry | Microscopy | Cell lines | Antitumor activity | In vivo methods and tests | Kinetics | Conjugation | Annexin V | Combinatorial analysis | Cancer
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 11/2018, Volume 35, Issue 11, pp. 1 - 11
Bendamustine is an important drug for the treatment of chronic lymphatic leukaemia (CLL), non-Hodgkin lymphoma (NHL). However, its delivery is challenging due...
Biochemistry, general | Biomedical Engineering | THP-1 | Biomedicine | nanoparticles | PLGA | Pharmacy | Medical Law | eat | Pharmacology/Toxicology | bendamustine | EFFICACY | VIVO | STABILITY | CHEMISTRY, MULTIDISCIPLINARY | HYDROCHLORIDE | PACLITAXEL | IN-VITRO | PHARMACOLOGY & PHARMACY | ANTICANCER DRUG-DELIVERY | Nanoparticles | Antimitotic agents | Lymphomas | Antineoplastic agents | Analysis | Leukemia | Particle size | Size distribution | Chronic lymphatic leukemia | Stability | Toxicity | Cytology | Regression | Cytotoxicity | Electron microscopy | Lymphoma | Polylactide-co-glycolide | Particle size distribution | Zeta potential | Morphology | Polydispersity | Biocompatibility | In vivo methods and tests | Apoptosis | Tumors | Index Medicus
Biochemistry, general | Biomedical Engineering | THP-1 | Biomedicine | nanoparticles | PLGA | Pharmacy | Medical Law | eat | Pharmacology/Toxicology | bendamustine | EFFICACY | VIVO | STABILITY | CHEMISTRY, MULTIDISCIPLINARY | HYDROCHLORIDE | PACLITAXEL | IN-VITRO | PHARMACOLOGY & PHARMACY | ANTICANCER DRUG-DELIVERY | Nanoparticles | Antimitotic agents | Lymphomas | Antineoplastic agents | Analysis | Leukemia | Particle size | Size distribution | Chronic lymphatic leukemia | Stability | Toxicity | Cytology | Regression | Cytotoxicity | Electron microscopy | Lymphoma | Polylactide-co-glycolide | Particle size distribution | Zeta potential | Morphology | Polydispersity | Biocompatibility | In vivo methods and tests | Apoptosis | Tumors | Index Medicus
Journal Article
Journal of Hazardous Materials, ISSN 0304-3894, 2010, Volume 178, Issue 1, pp. 814 - 822
The safe mining of sulfide ores requires knowledge of the stability/reactivity of the ores under a variety of conditions. This is a large part due to the...
Iso-conversional methods | Sulfide minerals | Oxidation kinetic | DSC | Self-heating | OXIDATION | MECHANISM | STATE | DIFFERENTIAL SCANNING CALORIMETRY | COMPUTATIONAL ASPECTS | DEPOSIT | FERRIC IRON | ENVIRONMENTAL SCIENCES | THERMOGRAVIMETRIC DATA | ENGINEERING, CIVIL | ENGINEERING, ENVIRONMENTAL | ICTAC KINETICS PROJECT | ACTIVATION-ENERGY | Thermodynamics | Algorithms | Sulfides - chemistry | Calorimetry, Differential Scanning | Minerals - chemistry | Catalysis | Hot Temperature | Kinetics | Models, Statistical | Concentrates (ores) | Sulfides | Differential scanning calorimetry | Ores | Simulation | Mathematical analysis | Reaction kinetics | Minerals
Iso-conversional methods | Sulfide minerals | Oxidation kinetic | DSC | Self-heating | OXIDATION | MECHANISM | STATE | DIFFERENTIAL SCANNING CALORIMETRY | COMPUTATIONAL ASPECTS | DEPOSIT | FERRIC IRON | ENVIRONMENTAL SCIENCES | THERMOGRAVIMETRIC DATA | ENGINEERING, CIVIL | ENGINEERING, ENVIRONMENTAL | ICTAC KINETICS PROJECT | ACTIVATION-ENERGY | Thermodynamics | Algorithms | Sulfides - chemistry | Calorimetry, Differential Scanning | Minerals - chemistry | Catalysis | Hot Temperature | Kinetics | Models, Statistical | Concentrates (ores) | Sulfides | Differential scanning calorimetry | Ores | Simulation | Mathematical analysis | Reaction kinetics | Minerals
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 10/2017, Volume 23, Issue 35, pp. 5315 - 5326
Background: Delivery of chemotherapeutic drugs for the diagnosis and treatment of cancer is becoming advanced day by day. However, the challenge of the...
Dendrimers | Polymeric nanoparticles | Nano-carriers | Quantum dots | Breast cancer | Liposomes | Nanoshells | Polymeric micelles | STEM-CELLS | polymeric nanoparticles | dendrimers | liposomes | DRUG-DELIVERY | YOUNGER WOMEN | breast cancer | ANTICANCER DRUG | MICELLES | nanoshells | quantum dots | NANOPARTICLES | polymeric micelles | PHOTOTHERMAL THERAPY | IN-VIVO | ENHANCED EFFICACY | PHARMACOLOGY & PHARMACY
Dendrimers | Polymeric nanoparticles | Nano-carriers | Quantum dots | Breast cancer | Liposomes | Nanoshells | Polymeric micelles | STEM-CELLS | polymeric nanoparticles | dendrimers | liposomes | DRUG-DELIVERY | YOUNGER WOMEN | breast cancer | ANTICANCER DRUG | MICELLES | nanoshells | quantum dots | NANOPARTICLES | polymeric micelles | PHOTOTHERMAL THERAPY | IN-VIVO | ENHANCED EFFICACY | PHARMACOLOGY & PHARMACY
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 9/2017, Volume 34, Issue 9, pp. 1944 - 1955
First line antiTB drugs have several physical and toxic manifestations which limit their applications. RIF is a hydrophobic drug and has low water solubility...
Biochemistry, general | Biomedical Engineering | MABA | Biomedicine | Pharmacy | tuberculosis | co-polymeric micelles | Medical Law | HPMA-PLA conjugate | Pharmacology/Toxicology | NANOPARTICLES | CHITOSAN | NANOCARRIERS | PHARMACOLOGY & PHARMACY | COPOLYMERS | CHEMISTRY, MULTIDISCIPLINARY | PACLITAXEL | Hemolysis - drug effects | Polyesters - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | Delayed-Action Preparations - chemistry | Methacrylates - chemistry | Antibiotics, Antitubercular - pharmacology | Mycobacterium tuberculosis - drug effects | Polyesters - chemistry | Rifampin - adverse effects | Delayed-Action Preparations - adverse effects | Methacrylates - adverse effects | Micelles | Tuberculosis - drug therapy | Drug Liberation | Kinetics | Rifampin - administration & dosage | Rifampin - pharmacology | Antibiotics, Antitubercular - administration & dosage | Drugs | Drug delivery systems | Tuberculosis | Analysis | Antitubercular agents | Nuclear magnetic resonance spectroscopy | Polymers | Patient compliance | Vehicles | Infrared spectroscopy | Fourier transforms | Microscopic analysis | Toxicity | Cytotoxicity | Drug delivery | Hydrophobicity | Phospholipase A | Strain | Magnetic resonance spectroscopy | Entrapment | Zeta potential | Minimum inhibitory concentration | Sustained release | NMR spectroscopy | Chemical synthesis | In vitro methods and tests | Controlled release | Index Medicus
Biochemistry, general | Biomedical Engineering | MABA | Biomedicine | Pharmacy | tuberculosis | co-polymeric micelles | Medical Law | HPMA-PLA conjugate | Pharmacology/Toxicology | NANOPARTICLES | CHITOSAN | NANOCARRIERS | PHARMACOLOGY & PHARMACY | COPOLYMERS | CHEMISTRY, MULTIDISCIPLINARY | PACLITAXEL | Hemolysis - drug effects | Polyesters - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | Delayed-Action Preparations - chemistry | Methacrylates - chemistry | Antibiotics, Antitubercular - pharmacology | Mycobacterium tuberculosis - drug effects | Polyesters - chemistry | Rifampin - adverse effects | Delayed-Action Preparations - adverse effects | Methacrylates - adverse effects | Micelles | Tuberculosis - drug therapy | Drug Liberation | Kinetics | Rifampin - administration & dosage | Rifampin - pharmacology | Antibiotics, Antitubercular - administration & dosage | Drugs | Drug delivery systems | Tuberculosis | Analysis | Antitubercular agents | Nuclear magnetic resonance spectroscopy | Polymers | Patient compliance | Vehicles | Infrared spectroscopy | Fourier transforms | Microscopic analysis | Toxicity | Cytotoxicity | Drug delivery | Hydrophobicity | Phospholipase A | Strain | Magnetic resonance spectroscopy | Entrapment | Zeta potential | Minimum inhibitory concentration | Sustained release | NMR spectroscopy | Chemical synthesis | In vitro methods and tests | Controlled release | Index Medicus
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 09/2015, Volume 21, Issue 30, pp. 4519 - 4526
In the last two decades, dendrimers have proven their capabilities in drug delivery, physical stabilization of the drug, solubility enhancement of the poorly...
Cardiovascular disease | Dendrimer | Nitric oxide donor | Adenosine receptors | Thrombosis | cardiovascular disease | A ADENOSINE RECEPTOR | DRUG-DELIVERY | PAMAM DENDRIMERS | COMPLEXES | MURINE CARDIAC TRANSPLANTS | thrombosis | FORMULATIONS | adenosine receptors | POLY(PROPYLENE IMINE) DENDRIMERS | IN-VIVO | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | GENE-TRANSFER | nitric oxide donor | Dendrimers - chemistry | Animals | Nanoparticles - chemistry | Cardiovascular Diseases - drug therapy | Humans | Drug Carriers - chemistry
Cardiovascular disease | Dendrimer | Nitric oxide donor | Adenosine receptors | Thrombosis | cardiovascular disease | A ADENOSINE RECEPTOR | DRUG-DELIVERY | PAMAM DENDRIMERS | COMPLEXES | MURINE CARDIAC TRANSPLANTS | thrombosis | FORMULATIONS | adenosine receptors | POLY(PROPYLENE IMINE) DENDRIMERS | IN-VIVO | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | GENE-TRANSFER | nitric oxide donor | Dendrimers - chemistry | Animals | Nanoparticles - chemistry | Cardiovascular Diseases - drug therapy | Humans | Drug Carriers - chemistry
Journal Article
9.
Full Text
Kinetics and safety analysis of sulfide mineral self-heating Part I. Effect of mineralogy
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, ISSN 1388-6150, 10/2011, Volume 106, Issue 1, pp. 53 - 61
Thermal methods of analysis such as DSC and TGA provide a powerful methodology for the study of solid reactions. This paper proposes an improved thermal...
OXIDATION | PYRITE | CHEMISTRY, ANALYTICAL | MECHANISM | CHEMISTRY, PHYSICAL | IRON | PYRRHOTITE | TGA | CONCENTRATE | DSC | Thermal safety | TMR | Kinetics | Thermal analysis | Sulfides | Analysis | Safety and security measures
OXIDATION | PYRITE | CHEMISTRY, ANALYTICAL | MECHANISM | CHEMISTRY, PHYSICAL | IRON | PYRRHOTITE | TGA | CONCENTRATE | DSC | Thermal safety | TMR | Kinetics | Thermal analysis | Sulfides | Analysis | Safety and security measures
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 10/2017, Volume 14, Issue 10, pp. 3356 - 3369
Journal Article
Journal of Thermal Analysis and Calorimetry, ISSN 1388-6150, 10/2011, Volume 106, Issue 1, pp. 53 - 61
Thermal methods of analysis such as DSC and TGA provide a powerful methodology for the study of solid reactions. This paper proposes an improved thermal...
Polymer Sciences | Chemistry | Analytical Chemistry | Measurement Science and Instrumentation | Physical Chemistry | DSC | Thermal safety | TMR | Inorganic Chemistry | Kinetics | Thermal analysis | TGA
Polymer Sciences | Chemistry | Analytical Chemistry | Measurement Science and Instrumentation | Physical Chemistry | DSC | Thermal safety | TMR | Inorganic Chemistry | Kinetics | Thermal analysis | TGA
Journal Article
Materials Science & Engineering. C, Biomimetic Materials, Sensors and Systems, ISSN 0928-4931, 03/2017, Volume 72, p. 611
Bortezomib (BTZ) is the first proteasome inhibitor approved by the US-FDA is majorly used for the treatment of newly diagnosed and relapsed multiple myeloma...
Formulations | Polypropyleneimine | Inhibitor drugs | Bortezomib | Multiple myeloma | Solubility | Hydrophobicity | Solubilization | Electrostatic properties | pH effects | Hydrogen bonding | Lymphoma | Propylene | Thermodynamics | Dendrimers | Hydrogen bonds | Hydrogen ions | Simulation | Mantle cell lymphoma | Chemical bonds | Schroedinger equation | Bonding
Formulations | Polypropyleneimine | Inhibitor drugs | Bortezomib | Multiple myeloma | Solubility | Hydrophobicity | Solubilization | Electrostatic properties | pH effects | Hydrogen bonding | Lymphoma | Propylene | Thermodynamics | Dendrimers | Hydrogen bonds | Hydrogen ions | Simulation | Mantle cell lymphoma | Chemical bonds | Schroedinger equation | Bonding
Journal Article
Thermochimica Acta, ISSN 0040-6031, 2010, Volume 501, Issue 1, pp. 35 - 45
Thermal methods of analysis such as differential scanning calorimetry (DSC) provide a powerful methodology for the study of solid reactions. This paper...
Iso-conversional methods | Sulfide minerals | Oxidation kinetics | MLA | DSC | Self-heating | OXIDATION | CHEMISTRY, ANALYTICAL | CHEMISTRY, PHYSICAL | IRON | MODEL | PYRRHOTITE | ACTIVATION-ENERGY
Iso-conversional methods | Sulfide minerals | Oxidation kinetics | MLA | DSC | Self-heating | OXIDATION | CHEMISTRY, ANALYTICAL | CHEMISTRY, PHYSICAL | IRON | MODEL | PYRRHOTITE | ACTIVATION-ENERGY
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 05/2017, Volume 98, pp. 810 - 819
Taxanes have established and proven effectivity against different types of cancers; in particular breast cancers. However, the high hemolytic toxicity and...
Nanoparticles | Nano-emulsion | Chitosan | Biodegradable polymers | Paclitaxel | POLYMER SCIENCE | DELIVERY SYSTEMS | MICROTUBULES | STABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | CREMOPHOR-EL | DRUG-RELEASE | FORMULATION | CANCER | IN-VITRO | TAXOL | CHEMISTRY, APPLIED | CYTOTOXICITY | Nanoparticles - chemistry | Humans | Chitosan - administration & dosage | Antineoplastic Agents, Phytogenic - chemistry | Polyethylene Glycols - chemistry | Breast Neoplasms - drug therapy | Drug Carriers - chemistry | Drug Delivery Systems | Particle Size | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Chitosan - chemistry | Cell Line, Tumor | Female | Nanoparticles - administration & dosage | Paclitaxel - administration & dosage | Antimitotic agents | Care and treatment | Pharmacy | Drugstores | Antineoplastic agents | Cancer | Apoptosis | Nanotechnology | Index Medicus
Nanoparticles | Nano-emulsion | Chitosan | Biodegradable polymers | Paclitaxel | POLYMER SCIENCE | DELIVERY SYSTEMS | MICROTUBULES | STABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | CREMOPHOR-EL | DRUG-RELEASE | FORMULATION | CANCER | IN-VITRO | TAXOL | CHEMISTRY, APPLIED | CYTOTOXICITY | Nanoparticles - chemistry | Humans | Chitosan - administration & dosage | Antineoplastic Agents, Phytogenic - chemistry | Polyethylene Glycols - chemistry | Breast Neoplasms - drug therapy | Drug Carriers - chemistry | Drug Delivery Systems | Particle Size | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Chitosan - chemistry | Cell Line, Tumor | Female | Nanoparticles - administration & dosage | Paclitaxel - administration & dosage | Antimitotic agents | Care and treatment | Pharmacy | Drugstores | Antineoplastic agents | Cancer | Apoptosis | Nanotechnology | Index Medicus
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 06/2018, Volume 15, Issue 6, pp. 2084 - 2097
Successful delivery of a chemotherapeutic agent like bendamustine still remains a challenge in clinical conditions like chronic lymphatic leukemia (CLL),...
drug-dendrimer conjugate | multiple myeloma | non-Hodgkin lymphoma | chronic lymphatic leukemia | PAMAM dendrimer | bendamustine | MEDICINE, RESEARCH & EXPERIMENTAL | REFRACTORY MULTIPLE-MYELOMA | DRUG-DELIVERY | PHASE-II | INDOLENT B-CELL | ANTICANCER EFFICACY | NANOPARTICLES | METASTATIC BREAST-CANCER | PHARMACOLOGY & PHARMACY | OLD DRUG | POLY(AMIDOAMINE) DENDRIMERS | RELEASE KINETICS | Cell Survival - drug effects | Polyamines - chemistry | Rats, Wistar | Apoptosis - drug effects | Humans | Rats | Carcinoma, Ehrlich Tumor - drug therapy | Treatment Outcome | Antineoplastic Agents, Alkylating - pharmacokinetics | Antineoplastic Agents, Alkylating - administration & dosage | Bendamustine Hydrochloride - pharmacokinetics | Delayed-Action Preparations - administration & dosage | Tissue Distribution | Bendamustine Hydrochloride - administration & dosage | Animals | Delayed-Action Preparations - pharmacokinetics | Cell Line, Tumor | Dendrimers - chemistry | Drug Liberation | Mice | Mice, Inbred BALB C | Neoplasms, Experimental - drug therapy | Nanoconjugates - chemistry | Drug Screening Assays, Antitumor
drug-dendrimer conjugate | multiple myeloma | non-Hodgkin lymphoma | chronic lymphatic leukemia | PAMAM dendrimer | bendamustine | MEDICINE, RESEARCH & EXPERIMENTAL | REFRACTORY MULTIPLE-MYELOMA | DRUG-DELIVERY | PHASE-II | INDOLENT B-CELL | ANTICANCER EFFICACY | NANOPARTICLES | METASTATIC BREAST-CANCER | PHARMACOLOGY & PHARMACY | OLD DRUG | POLY(AMIDOAMINE) DENDRIMERS | RELEASE KINETICS | Cell Survival - drug effects | Polyamines - chemistry | Rats, Wistar | Apoptosis - drug effects | Humans | Rats | Carcinoma, Ehrlich Tumor - drug therapy | Treatment Outcome | Antineoplastic Agents, Alkylating - pharmacokinetics | Antineoplastic Agents, Alkylating - administration & dosage | Bendamustine Hydrochloride - pharmacokinetics | Delayed-Action Preparations - administration & dosage | Tissue Distribution | Bendamustine Hydrochloride - administration & dosage | Animals | Delayed-Action Preparations - pharmacokinetics | Cell Line, Tumor | Dendrimers - chemistry | Drug Liberation | Mice | Mice, Inbred BALB C | Neoplasms, Experimental - drug therapy | Nanoconjugates - chemistry | Drug Screening Assays, Antitumor
Journal Article
Journal of Thermal Analysis and Calorimetry, ISSN 1388-6150, 10/2011, Volume 106, Issue 1, pp. 53 - 61
Thermal methods of analysis such as DSC and TGA provide a powerful methodology for the study of solid reactions. This paper proposes an improved thermal...
Differential scanning calorimetry | Sulfides | Methodology | Mineralogy | Aids | Minerals | Safety | Thermal analysis
Differential scanning calorimetry | Sulfides | Methodology | Mineralogy | Aids | Minerals | Safety | Thermal analysis
Journal Article
AAPS PharmSciTech, ISSN 1530-9932, 10/2018, Volume 19, Issue 7, pp. 3237 - 3248
In an attempt to deliver multiple drugs through a nanoparticulate platform, the present study was designed to deliver isoniazid (INH) and rifampicin (RMP)...
Biochemistry, general | Biotechnology | rifampicin | Biomedicine | polymeric micelles (PMC) | isoniazid | Pharmacy | Pharmacology/Toxicology | dual drug delivery | tuberculosis (TB) | EFFICACY | PROTEIN-BINDING | POLYMERIC MICELLES | FORMULATION | CHEMOTHERAPY | PACLITAXEL | NANOPARTICLES | PEG | BACK | PHARMACOLOGY & PHARMACY | COPOLYMER | Humans | Micelles | Polyethylene Glycols - chemistry | Rifampin - administration & dosage | Mycobacterium tuberculosis - drug effects | Drug Delivery Systems | Isoniazid - administration & dosage | Drugs | Drug delivery systems | Tuberculosis | Polyethylene glycol | Rifampin | Isoniazid | Polyols | Organic acids | Vehicles
Biochemistry, general | Biotechnology | rifampicin | Biomedicine | polymeric micelles (PMC) | isoniazid | Pharmacy | Pharmacology/Toxicology | dual drug delivery | tuberculosis (TB) | EFFICACY | PROTEIN-BINDING | POLYMERIC MICELLES | FORMULATION | CHEMOTHERAPY | PACLITAXEL | NANOPARTICLES | PEG | BACK | PHARMACOLOGY & PHARMACY | COPOLYMER | Humans | Micelles | Polyethylene Glycols - chemistry | Rifampin - administration & dosage | Mycobacterium tuberculosis - drug effects | Drug Delivery Systems | Isoniazid - administration & dosage | Drugs | Drug delivery systems | Tuberculosis | Polyethylene glycol | Rifampin | Isoniazid | Polyols | Organic acids | Vehicles
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 11/2016, Volume 92, pp. 1242 - 1251
Bendamustine is a drug of choice for the treatment of several cancers including non- Hodgkin lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). The...
Nanoparticles | PEG-PLGA conjugate | Bendamustine | PLGA nanoparticles | POLYMER SCIENCE | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOXORUBICIN | PLGA-BASED NANOPARTICLES | PACLITAXEL | BREAST-CANCER | CO-DELIVERY | POLYMERIC NANOPARTICLES | THERAPY | CHEMISTRY, APPLIED | DRUG-DELIVERY SYSTEMS | Hemolysis - drug effects | Cell Survival - drug effects | Nanoparticles - chemistry | Drug Stability | Humans | Nanoparticles - ultrastructure | Antineoplastic Agents, Alkylating - pharmacology | Male | Polyethylene Glycols - chemistry | Drug Carriers | Erythrocytes - drug effects | Particle Size | Polyesters - chemistry | MCF-7 Cells | Bendamustine Hydrochloride - pharmacology | Cell Line, Tumor | Drug Compounding | Drug Liberation | Bendamustine Hydrochloride - chemistry | Female | Kinetics | Antineoplastic Agents, Alkylating - chemistry | Antimitotic agents | Care and treatment | Pharmacy | Leukemia | Drugstores | Nuclear magnetic resonance spectroscopy | Lymphomas | Antineoplastic agents | Cancer | Index Medicus
Nanoparticles | PEG-PLGA conjugate | Bendamustine | PLGA nanoparticles | POLYMER SCIENCE | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOXORUBICIN | PLGA-BASED NANOPARTICLES | PACLITAXEL | BREAST-CANCER | CO-DELIVERY | POLYMERIC NANOPARTICLES | THERAPY | CHEMISTRY, APPLIED | DRUG-DELIVERY SYSTEMS | Hemolysis - drug effects | Cell Survival - drug effects | Nanoparticles - chemistry | Drug Stability | Humans | Nanoparticles - ultrastructure | Antineoplastic Agents, Alkylating - pharmacology | Male | Polyethylene Glycols - chemistry | Drug Carriers | Erythrocytes - drug effects | Particle Size | Polyesters - chemistry | MCF-7 Cells | Bendamustine Hydrochloride - pharmacology | Cell Line, Tumor | Drug Compounding | Drug Liberation | Bendamustine Hydrochloride - chemistry | Female | Kinetics | Antineoplastic Agents, Alkylating - chemistry | Antimitotic agents | Care and treatment | Pharmacy | Leukemia | Drugstores | Nuclear magnetic resonance spectroscopy | Lymphomas | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 03/2017, Volume 72, pp. 611 - 619
Bortezomib (BTZ) is the first proteasome inhibitor approved by the US-FDA is majorly used for the treatment of newly diagnosed and relapsed multiple myeloma...
PPI | Thermodynamics | Dendrimer | Solubilization | PAMAM | MULTIPLE-MYELOMA | BONE-DISEASE | MATERIALS SCIENCE, BIOMATERIALS | ANTICANCER DRUG | RELEASE | BIOAVAILABILITY | DELIVERY | PATHOGENESIS | THERAPY | PRODRUG | PROTEASOME | Bortezomib - metabolism | Solubility | Antineoplastic Agents - chemistry | Static Electricity | Drug Carriers - chemistry | Molecular Dynamics Simulation | Antineoplastic Agents - metabolism | Hydrogen Bonding | Bortezomib - chemistry | Water - chemistry | Dendrimers - chemistry | Drug Liberation | Hydrophobic and Hydrophilic Interactions | Polypropylenes - chemistry | Hydrogen-Ion Concentration | Dendrimers | Bortezomib | Hydrogen | Drug approval | Multiple myeloma | Formulations | Drugs | Simulation | pH
PPI | Thermodynamics | Dendrimer | Solubilization | PAMAM | MULTIPLE-MYELOMA | BONE-DISEASE | MATERIALS SCIENCE, BIOMATERIALS | ANTICANCER DRUG | RELEASE | BIOAVAILABILITY | DELIVERY | PATHOGENESIS | THERAPY | PRODRUG | PROTEASOME | Bortezomib - metabolism | Solubility | Antineoplastic Agents - chemistry | Static Electricity | Drug Carriers - chemistry | Molecular Dynamics Simulation | Antineoplastic Agents - metabolism | Hydrogen Bonding | Bortezomib - chemistry | Water - chemistry | Dendrimers - chemistry | Drug Liberation | Hydrophobic and Hydrophilic Interactions | Polypropylenes - chemistry | Hydrogen-Ion Concentration | Dendrimers | Bortezomib | Hydrogen | Drug approval | Multiple myeloma | Formulations | Drugs | Simulation | pH
Journal Article